Insider · CIK 0001838777
Renee Lentini
Files at IMGN (ImmunoGen, Inc.). First filing Nov 8, 2023, latest Feb 6, 2024.
In brief
Renee Lentini files SEC Form 4 as officer at IMGN (ImmunoGen, Inc.). Since Nov 8, 2023, Renee Lentini has reported 0 open-market buys worth $0 and 3 open-market sells worth $3.6M, the latest filed on Feb 6, 2024.
A track record needs three past buys with six months of prices behind them; Renee Lentini has 0, so none is measured yet.
The newest scored trade: sold $77k of IMGN on Feb 5, 2024, filed Feb 6, 2024, scored 8 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | ImmunoGen, Inc. | $77k 2,631 shares | -15% | - | |
| 10Weak | ImmunoGen, Inc. | $195k 6,548 shares | -44% | - | |
| 60Notable | ImmunoGen, Inc. | $3.4M 219,545 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 5, 2024 | IMGN ImmunoGen, Inc. | 2,631 0.00% of outstanding | $77k | Feb 5, 2024 | $3.6M |
| Dec 26, 2023 | ImmunoGen, Inc. | 6,548 0.00% of outstanding | $195k | Dec 26, 2023 | $3.4M |
| Nov 6, 2023 | ImmunoGen, Inc. | 219,545 0.08% of outstanding | $3.4M | Nov 6, 2023 | none |
Transactions
Every row this insider has filed, 32 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Common Stock | -14,723 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -39,370 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,250 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,555 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,625 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,250 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -53,831 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,610 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -10,139 | - | - | 0 | Feb 12, 2024 |
| Feb 2, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +8,435 | $0.00 | $0 | 17,354 | Feb 6, 2024 |
| Feb 5, 2024 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -2,631 | $29.30 | $77k | 14,723 | Feb 6, 2024 |
| Feb 2, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Restricted Stock Unitderivative10b5-1 | -8,435 | $0.00 | $0 | 16,870 | Feb 6, 2024 |
| Feb 1, 2024 | IMGN ImmunoGen, Inc. | AGrant or award Restricted Stock Unitderivative | +10,139 | $0.00 | $0 | 10,139 | Feb 5, 2024 |
| Dec 29, 2023 | IMGN ImmunoGen, Inc. | AGrant or award Common Stock | +467 | $16.01 | $7,477 | 8,919 | Jan 3, 2024 |
| Dec 22, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +15,000 | $0.00 | $0 | 15,000 | Dec 27, 2023 |
| Dec 26, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -6,548 | $29.74 | $195k | 8,452 | Dec 27, 2023 |
| Dec 22, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Restricted Stock Unitderivative10b5-1 | -15,000 | $0.00 | $0 | 22,500 | Dec 27, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +9,000 | $10.79 | $97k | 108,017 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +2,619 | $2.68 | $7,019 | 110,636 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +23,000 | $10.65 | $245k | 133,636 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +14,373 | $5.25 | $75k | 148,009 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +4,024 | $6.98 | $28k | 152,033 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +55,550 | $7.69 | $427k | 207,583 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +11,962 | $5.32 | $64k | 219,545 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock | -219,545 | $15.29 | $3.4M | 0 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative | -9,000 | $0.00 | $0 | 0 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative | -2,619 | $0.00 | $0 | 0 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative | -23,000 | $0.00 | $0 | 0 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative | -14,373 | $0.00 | $0 | 0 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative | -4,024 | $0.00 | $0 | 12,625 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative | -55,550 | $0.00 | $0 | 25,250 | Nov 8, 2023 |
| Nov 6, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative | -11,962 | $0.00 | $0 | 53,831 | Nov 8, 2023 |
Questions about Renee Lentini
Answered from the filings on this page, as of the latest one.
Is Renee Lentini buying or selling?
Not in the last 12 months. Renee Lentini's latest open-market trade on SEC Form 4 was sold $77k of IMGN on Feb 5, 2024.
How did Renee Lentini's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Renee Lentini has 0.
Where does Renee Lentini file Form 4?
Renee Lentini has filed Form 4 at IMGN (ImmunoGen, Inc.) as VP & PRIN ACCTG OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.